Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence - A Prospective Randomized Evaluation of Response and Toxicity

NCT03303365 is registered in ClinicalTrials.gov with Juergen Debus as lead sponsor.

NCT NCT03303365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03303365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence - A Prospective Randomized Evaluation of Response and Toxicity
Lead sponsor
Juergen Debus
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2018
Completion date
June 1, 2021
Enrollment
203 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult solid tumor, brain metastases